{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:42:59Z","timestamp":1784122979110,"version":"3.55.0"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04828-1","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T19:15:57Z","timestamp":1774206957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Insulin resistance as a modifiable contributor to breast cancer: mechanisms, biomarkers, and therapeutic implications"],"prefix":"10.1007","volume":"17","author":[{"given":"Seyed Parsa","family":"Marouf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Meskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,22]]},"reference":[{"key":"4828_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15\u201323.","journal-title":"Breast"},{"issue":"1","key":"4828_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4828_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/2279-042X.132704","volume":"3","author":"A Surakasula","year":"2014","unstructured":"Surakasula A, Nagarjunapu GC, Raghavaiah KV. A comparative study of pre- and post-menopausal breast cancer: risk factors, presentation, characteristics and management. J Res Pharm Pract. 2014;3(1):12\u20138.","journal-title":"J Res Pharm Pract"},{"issue":"2","key":"4828_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/2042098614568300","volume":"6","author":"RT Chlebowski","year":"2015","unstructured":"Chlebowski RT, Anderson GL. Menopausal hormone therapy and breast cancer mortality: clinical implications. Ther Adv Drug Saf. 2015;6(2):45\u201356.","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"4828_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10549-007-9632-6","volume":"109","author":"RC Millikan","year":"2008","unstructured":"Millikan RC, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008;109(1):123\u201339.","journal-title":"Breast Cancer Res Treat"},{"issue":"D1","key":"4828_CR6","doi-asserted-by":"publisher","first-page":"D835","DOI":"10.1093\/nar\/gkz972","volume":"48","author":"MJ Landrum","year":"2020","unstructured":"Landrum MJ, et al. ClinVar: improvements to accessing data. Nucleic Acids Res. 2020;48(D1):D835-d844.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"4828_CR7","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98(4):2133\u2013223.","journal-title":"Physiol Rev"},{"key":"4828_CR8","volume-title":"Insulin resistance","author":"AM Freeman","year":"2025","unstructured":"Freeman AM, Acevedo LA, Pennings N. Insulin resistance. Treasure Island (FL): StatPearls Publishing LLC; 2025."},{"issue":"1","key":"4828_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","volume":"582","author":"C de Luca","year":"2008","unstructured":"de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008;582(1):97\u2013105.","journal-title":"FEBS Lett"},{"issue":"5","key":"4828_CR10","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"Hotamisligil GS, et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95(5):2409\u201315.","journal-title":"J Clin Invest"},{"key":"4828_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/789174","volume":"2012","author":"B Arcidiacono","year":"2012","unstructured":"Arcidiacono B, et al. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res. 2012;2012:789174.","journal-title":"Exp Diabetes Res"},{"key":"4828_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104741","volume":"155","author":"F Zhang","year":"2020","unstructured":"Zhang F, Liu S. Mechanistic insights of adipocyte metabolism in regulating breast cancer progression. Pharmacol Res. 2020;155:104741.","journal-title":"Pharmacol Res"},{"issue":"10","key":"4828_CR13","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1158\/0008-5472.CAN-18-3688","volume":"79","author":"SY Jung","year":"2019","unstructured":"Jung SY, et al. Breast cancer risk and insulin resistance: post genome-wide gene-environment interaction study using a random survival forest. Cancer Res. 2019;79(10):2784\u201394.","journal-title":"Cancer Res"},{"issue":"16","key":"4828_CR14","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1002\/cncr.33002","volume":"126","author":"K Pan","year":"2020","unstructured":"Pan K, et al. Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women\u2019s Health Initiative. Cancer. 2020;126(16):3638\u201347.","journal-title":"Cancer"},{"issue":"1","key":"4828_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13058-020-01281-y","volume":"22","author":"EJ Gallagher","year":"2020","unstructured":"Gallagher EJ, et al. Insulin resistance contributes to racial disparities in breast cancer prognosis in US women. Breast Cancer Res. 2020;22(1):40.","journal-title":"Breast Cancer Res"},{"issue":"11","key":"4828_CR16","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1245\/s10434-021-09748-8","volume":"28","author":"NT Gordon","year":"2021","unstructured":"Gordon NT, et al. Association of insulin resistance and higher Oncotype DX\u2122 recurrence score. Ann Surg Oncol. 2021;28(11):5941\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4828_CR17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1158\/0008-5472.CAN-09-2141","volume":"70","author":"R Novosyadlyy","year":"2010","unstructured":"Novosyadlyy R, et al. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res. 2010;70(2):741\u201351.","journal-title":"Cancer Res"},{"issue":"1","key":"4828_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/biom11010125","volume":"11","author":"F Biello","year":"2021","unstructured":"Biello F, et al. Insulin\/IGF axis in breast cancer: clinical evidence and translational insights. Biomolecules. 2021;11(1):125.","journal-title":"Biomolecules"},{"issue":"10","key":"4828_CR19","first-page":"2334","volume":"6","author":"W Sun","year":"2016","unstructured":"Sun W, et al. Association of insulin resistance with breast, ovarian, endometrial and cervical cancers in non-diabetic women. Am J Cancer Res. 2016;6(10):2334\u201344.","journal-title":"Am J Cancer Res"},{"issue":"4","key":"4828_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/0284186X.2023.2197124","volume":"62","author":"JM M\u00e0rmol","year":"2023","unstructured":"M\u00e0rmol JM, et al. Insulin resistance in patients with cancer: a systematic review and meta-analysis. Acta Oncol. 2023;62(4):364\u201371.","journal-title":"Acta Oncol"},{"issue":"2","key":"4828_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/01635581.2015.990569","volume":"67","author":"A Ghose","year":"2015","unstructured":"Ghose A, et al. A review of obesity, insulin resistance, and the role of exercise in breast cancer patients. Nutr Cancer. 2015;67(2):197\u2013202.","journal-title":"Nutr Cancer"},{"issue":"11","key":"4828_CR22","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1038\/s41416-024-02833-1","volume":"131","author":"SR Javed","year":"2024","unstructured":"Javed SR, et al. Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer. Br J Cancer. 2024;131(11):1724\u201336.","journal-title":"Br J Cancer"},{"issue":"1","key":"4828_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/1940-6207.CAPR-18-0180","volume":"12","author":"SY Jung","year":"2019","unstructured":"Jung SY, et al. Genome-wide meta-analysis of gene-environmental interaction for insulin resistance phenotypes and breast cancer risk in postmenopausal women. Cancer Prev Res (Phila). 2019;12(1):31\u201342.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"4828_CR24","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4828_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s44178-022-00007-8","volume":"1","author":"J Wu","year":"2022","unstructured":"Wu J, et al. CACA guidelines for holistic integrative management of breast cancer. Holist Integr Oncol. 2022;1(1):7.","journal-title":"Holist Integr Oncol"},{"issue":"1","key":"4828_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","volume":"10","author":"Y Xu","year":"2023","unstructured":"Xu Y, et al. Global trends and forecasts of breast cancer incidence and deaths. Sci Data. 2023;10(1):334.","journal-title":"Sci Data"},{"issue":"3","key":"4828_CR27","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"4828_CR28","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, et al. Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond). 2021;41(11):1183\u201394.","journal-title":"Cancer Commun (Lond)"},{"issue":"10430","key":"4828_CR29","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S0140-6736(23)02802-7","volume":"403","author":"M Hickey","year":"2024","unstructured":"Hickey M, et al. Managing menopause after cancer. Lancet. 2024;403(10430):984\u201396.","journal-title":"Lancet"},{"issue":"1","key":"4828_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s44178-022-00003-y","volume":"1","author":"Z Dong","year":"2022","unstructured":"Dong Z. Highlights of recent cancer research. Holist Integr Oncol. 2022;1(1):2.","journal-title":"Holist Integr Oncol"},{"issue":"10286","key":"4828_CR31","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, et al. Breast cancer. Lancet. 2021;397(10286):1750\u201369.","journal-title":"Lancet"},{"issue":"2","key":"4828_CR32","first-page":"198","volume":"48","author":"RD Nindrea","year":"2019","unstructured":"Nindrea RD, et al. Family history of breast cancer and breast cancer risk between Malays ethnicity in Malaysia and Indonesia: a meta-analysis. Iran J Public Health. 2019;48(2):198\u2013205.","journal-title":"Iran J Public Health"},{"issue":"5","key":"4828_CR33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"L Dorling","year":"2021","unstructured":"Dorling L, et al. Breast cancer risk genes - association analysis in more than 113,000 women. N Engl J Med. 2021;384(5):428\u201339.","journal-title":"N Engl J Med"},{"issue":"5","key":"4828_CR34","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","volume":"384","author":"C Hu","year":"2021","unstructured":"Hu C, et al. A population-based study of genes previously implicated in breast cancer. N Engl J Med. 2021;384(5):440\u201351.","journal-title":"N Engl J Med"},{"issue":"7","key":"4828_CR35","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1096\/fj.08-124073","volume":"23","author":"KD Yu","year":"2009","unstructured":"Yu KD, et al. A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer. Faseb j. 2009;23(7):2274\u201387.","journal-title":"Faseb j"},{"issue":"13","key":"4828_CR36","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1093\/hmg\/ddp171","volume":"18","author":"KD Yu","year":"2009","unstructured":"Yu KD, et al. Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53. Hum Mol Genet. 2009;18(13):2502\u201317.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"4828_CR37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1158\/0008-5472.CAN-11-2998","volume":"72","author":"KD Yu","year":"2012","unstructured":"Yu KD, et al. Genetic variants in oxidative stress-related genes predict chemoresistance in primary breast cancer: a prospective observational study and validation. Cancer Res. 2012;72(2):408\u201319.","journal-title":"Cancer Res"},{"issue":"4","key":"4828_CR38","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ccell.2024.03.006","volume":"42","author":"CJ Lin","year":"2024","unstructured":"Lin CJ, et al. Genetic interactions reveal distinct biological and therapeutic implications in breast cancer. Cancer Cell. 2024;42(4):701-719.e12.","journal-title":"Cancer Cell"},{"issue":"9084","key":"4828_CR39","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors for Breast Cancer","year":"1997","unstructured":"Collaborative Group on Hormonal Factors for Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 1997;350(9084):1047\u201359.","journal-title":"Lancet"},{"issue":"11","key":"4828_CR40","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","volume":"13","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2012","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012;13(11):1141\u201351.","journal-title":"Lancet Oncol"},{"issue":"6","key":"4828_CR41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.clbc.2014.04.003","volume":"14","author":"Y Cui","year":"2014","unstructured":"Cui Y, et al. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among White and African American women. Clin Breast Cancer. 2014;14(6):417\u201325.","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"4828_CR42","first-page":"227","volume":"25","author":"Y Huang","year":"2014","unstructured":"Huang Y, et al. A meta-analysis of the association between induced abortion and breast cancer risk among Chinese females. Cancer Causes Control. 2014;25(2):227\u201336.","journal-title":"Cancer Causes Control"},{"issue":"10","key":"4828_CR43","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S1470-2045(13)70301-2","volume":"14","author":"TJ Key","year":"2013","unstructured":"Key TJ, et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 2013;14(10):1009\u201319.","journal-title":"Lancet Oncol"},{"issue":"7","key":"4828_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001492","volume":"10","author":"RM Pfeiffer","year":"2013","unstructured":"Pfeiffer RM, et al. Risk prediction for breast, endometrial, and ovarian cancer in White women aged 50 y or older: derivation and validation from population-based cohort studies. PLoS Med. 2013;10(7):e1001492.","journal-title":"PLoS Med"},{"issue":"8","key":"4828_CR45","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/jnci\/djae056","volume":"116","author":"N Kumar","year":"2024","unstructured":"Kumar N, et al. The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis. J Natl Cancer Inst. 2024;116(8):1210\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4828_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10549-008-0069-3","volume":"115","author":"L Baglietto","year":"2009","unstructured":"Baglietto L, et al. Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition. Breast Cancer Res Treat. 2009;115(1):171\u20139.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"4828_CR47","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","volume":"94","author":"T Key","year":"2002","unstructured":"Key T, et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94(8):606\u201316.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"4828_CR48","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/bjc.2014.579","volume":"112","author":"V Bagnardi","year":"2015","unstructured":"Bagnardi V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112(3):580\u201393.","journal-title":"Br J Cancer"},{"issue":"8","key":"4828_CR49","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/jnci\/djt023","volume":"105","author":"MM Gaudet","year":"2013","unstructured":"Gaudet MM, et al. Active smoking and breast cancer risk: original cohort data and meta-analysis. J Natl Cancer Inst. 2013;105(8):515\u201325.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"4828_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003302","volume":"17","author":"KE Johnson","year":"2020","unstructured":"Johnson KE, et al. The relationship between circulating lipids and breast cancer risk: a Mendelian randomization study. PLoS Med. 2020;17(9):e1003302.","journal-title":"PLoS Med"},{"issue":"Suppl 3","key":"4828_CR51","doi-asserted-by":"publisher","first-page":"S545","DOI":"10.1245\/s10434-015-4596-y","volume":"22","author":"E Koo","year":"2015","unstructured":"Koo E, et al. Management and prevention of breast cancer after radiation to the chest for childhood, adolescent, and young adulthood malignancy. Ann Surg Oncol. 2015;22(Suppl 3):S545\u201351.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"4828_CR52","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.clnu.2018.09.013","volume":"38","author":"N Namazi","year":"2019","unstructured":"Namazi N, et al. The association between fat mass and the risk of breast cancer: a systematic review and meta-analysis. Clin Nutr. 2019;38(4):1496\u2013503.","journal-title":"Clin Nutr"},{"issue":"12","key":"4828_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv275","volume":"107","author":"MC Playdon","year":"2015","unstructured":"Playdon MC, et al. Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis. J Natl Cancer Inst. 2015;107(12):djv275.","journal-title":"J Natl Cancer Inst"},{"key":"4828_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3857","volume":"354","author":"HH Kyu","year":"2016","unstructured":"Kyu HH, et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. BMJ. 2016;354:i3857.","journal-title":"BMJ"},{"issue":"25","key":"4828_CR55","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1200\/JCO.23.01959","volume":"42","author":"D Soldato","year":"2024","unstructured":"Soldato D, et al. Dose\/exposure relationship of exercise and distant recurrence in primary breast cancer. J Clin Oncol. 2024;42(25):3022\u201332.","journal-title":"J Clin Oncol"},{"issue":"7917","key":"4828_CR56","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41586-022-04875-y","volume":"607","author":"Z Diamantopoulou","year":"2022","unstructured":"Diamantopoulou Z, et al. The metastatic spread of breast cancer accelerates during sleep. Nature. 2022;607(7917):156\u201362.","journal-title":"Nature"},{"issue":"10","key":"4828_CR57","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s12276-021-00681-0","volume":"53","author":"Y Lee","year":"2021","unstructured":"Lee Y. Roles of circadian clocks in cancer pathogenesis and treatment. Exp Mol Med. 2021;53(10):1529\u201338.","journal-title":"Exp Mol Med"},{"issue":"1","key":"4828_CR58","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41420-024-01960-1","volume":"10","author":"Y Zeng","year":"2024","unstructured":"Zeng Y, et al. Circadian rhythm regulates the function of immune cells and participates in the development of tumors. Cell Death Discov. 2024;10(1):199.","journal-title":"Cell Death Discov"},{"key":"4828_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.semcancer.2023.03.003","volume":"91","author":"C Miro","year":"2023","unstructured":"Miro C, et al. \u201cTime\u201d for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment. Semin Cancer Biol. 2023;91:99\u2013109.","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"4828_CR60","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8(12):915\u201328.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"4828_CR61","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2174\/138161207780249173","volume":"13","author":"A Belfiore","year":"2007","unstructured":"Belfiore A. The role of insulin receptor isoforms and hybrid insulin\/IGF-I receptors in human cancer. Curr Pharm Des. 2007;13(7):671\u201386.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"4828_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","volume":"46","author":"SE Kahn","year":"2003","unstructured":"Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 2003;46(1):3\u201319.","journal-title":"Diabetologia"},{"issue":"1","key":"4828_CR63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee SH, Park SY, Choi CS. Insulin resistance: From mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15\u201337.","journal-title":"Diabetes Metab J"},{"issue":"10","key":"4828_CR64","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1172\/JCI129190","volume":"129","author":"JP Mann","year":"2019","unstructured":"Mann JP, Savage DB. What lipodystrophies teach us about the metabolic syndrome. J Clin Invest. 2019;129(10):4009\u201321.","journal-title":"J Clin Invest"},{"issue":"5695","key":"4828_CR65","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1126\/science.1103160","volume":"306","author":"U Ozcan","year":"2004","unstructured":"Ozcan U, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306(5695):457\u201361.","journal-title":"Science"},{"issue":"5","key":"4828_CR66","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111\u20139.","journal-title":"J Clin Invest"},{"issue":"5","key":"4828_CR67","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","volume":"64","author":"PK Luukkonen","year":"2016","unstructured":"Luukkonen PK, et al. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol. 2016;64(5):1167\u201375.","journal-title":"J Hepatol"},{"issue":"7","key":"4828_CR68","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1053\/j.gastro.2012.03.003","volume":"142","author":"F Magkos","year":"2012","unstructured":"Magkos F, et al. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology. 2012;142(7):1444-6.e2.","journal-title":"Gastroenterology"},{"issue":"10","key":"4828_CR69","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.celrep.2017.05.035","volume":"19","author":"KW Ter Horst","year":"2017","unstructured":"Ter Horst KW, et al. Hepatic diacylglycerol-associated protein kinase C\u03b5 translocation links hepatic steatosis to hepatic insulin resistance in humans. Cell Rep. 2017;19(10):1997\u20132004.","journal-title":"Cell Rep"},{"issue":"11","key":"4828_CR70","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1194\/jlr.M010256","volume":"51","author":"JM Brown","year":"2010","unstructured":"Brown JM, et al. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance. J Lipid Res. 2010;51(11):3306\u201315.","journal-title":"J Lipid Res"},{"issue":"5","key":"4828_CR71","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1073\/pnas.1219456110","volume":"110","author":"JL Cantley","year":"2013","unstructured":"Cantley JL, et al. CGI-58 knockdown sequesters diacylglycerols in lipid droplets\/ER-preventing diacylglycerol-mediated hepatic insulin resistance. Proc Natl Acad Sci U S A. 2013;110(5):1869\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"4828_CR72","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/jnci\/djm231","volume":"99","author":"V Venkateswaran","year":"2007","unstructured":"Venkateswaran V, et al. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst. 2007;99(23):1793\u2013800.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"4828_CR73","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1073\/pnas.73.12.4536","volume":"73","author":"CK Osborne","year":"1976","unstructured":"Osborne CK, et al. Hormone responsive human breast cancer in long-term tissue culture: effect of insulin. Proc Natl Acad Sci U S A. 1976;73(12):4536\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4828_CR74","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/13813450801969715","volume":"114","author":"F Frasca","year":"2008","unstructured":"Frasca F, et al. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem. 2008;114(1):23\u201337.","journal-title":"Arch Physiol Biochem"},{"issue":"4","key":"4828_CR75","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.molmed.2006.02.003","volume":"12","author":"D Carling","year":"2006","unstructured":"Carling D. LKB1: a sweet side to Peutz-Jeghers syndrome? Trends Mol Med. 2006;12(4):144\u20137.","journal-title":"Trends Mol Med"},{"issue":"2","key":"4828_CR76","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn DM, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30(2):214\u201326.","journal-title":"Mol Cell"},{"issue":"3","key":"4828_CR77","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.molcel.2008.04.012","volume":"30","author":"DG Hardie","year":"2008","unstructured":"Hardie DG. AMPK and Raptor: matching cell growth to energy supply. Mol Cell. 2008;30(3):263\u20135.","journal-title":"Mol Cell"},{"issue":"1","key":"4828_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","volume":"1","author":"BB Kahn","year":"2005","unstructured":"Kahn BB, et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005;1(1):15\u201325.","journal-title":"Cell Metab"},{"issue":"7\u20138","key":"4828_CR79","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00018-007-6359-9","volume":"64","author":"JF Youngren","year":"2007","unstructured":"Youngren JF. Regulation of insulin receptor function. Cell Mol Life Sci. 2007;64(7\u20138):873\u201391.","journal-title":"Cell Mol Life Sci"},{"key":"4828_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168590","author":"M Khalid","year":"2021","unstructured":"Khalid M, et al. Insulin signal transduction perturbations in insulin resistance. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22168590.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4828_CR81","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","volume":"55","author":"KD Copps","year":"2012","unstructured":"Copps KD, White MF. Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia. 2012;55(10):2565\u201382.","journal-title":"Diabetologia"},{"key":"4828_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205007","author":"Y Chen","year":"2019","unstructured":"Chen Y, et al. Insulin receptor trafficking: consequences for insulin sensitivity and diabetes. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20205007.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4828_CR83","doi-asserted-by":"publisher","first-page":"19891","DOI":"10.3390\/ijms141019891","volume":"14","author":"G Daffu","year":"2013","unstructured":"Daffu G, et al. Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond. Int J Mol Sci. 2013;14(10):19891\u2013910.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4828_CR84","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cpt.148","volume":"98","author":"E Litwinoff","year":"2015","unstructured":"Litwinoff E, et al. Emerging targets for therapeutic development in diabetes and its complications: the RAGE signaling pathway. Clin Pharmacol Ther. 2015;98(2):135\u201344.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"4828_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tem.2013.08.002","volume":"25","author":"MB Manigrasso","year":"2014","unstructured":"Manigrasso MB, et al. Unlocking the biology of RAGE in diabetic microvascular complications. Trends Endocrinol Metab. 2014;25(1):15\u201322.","journal-title":"Trends Endocrinol Metab"},{"issue":"5-6","key":"4828_CR86","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.vph.2012.06.004","volume":"57","author":"R Ramasamy","year":"2012","unstructured":"Ramasamy R, Yan SF, Schmidt AM. The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes. Vascul Pharmacol. 2012;57(5\u20136):160\u20137.","journal-title":"Vascul Pharmacol"},{"key":"4828_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1475-2840-11-46","volume":"11","author":"H Li","year":"2012","unstructured":"Li H, et al. Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells. Cardiovasc Diabetol. 2012;11:46.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"4828_CR88","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/01.CIR.0000157156.85397.A1","volume":"111","author":"FH Seeger","year":"2005","unstructured":"Seeger FH, et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation. 2005;111(9):1184\u201391.","journal-title":"Circulation"},{"issue":"1","key":"4828_CR89","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.biopha.2009.03.002","volume":"64","author":"C Shen","year":"2010","unstructured":"Shen C, et al. Advanced glycation endproducts increase EPC apoptosis and decrease nitric oxide release via MAPK pathways. Biomed Pharmacother. 2010;64(1):35\u201343.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4828_CR90","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00395-008-0738-8","volume":"104","author":"C Sun","year":"2009","unstructured":"Sun C, et al. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1\/2 mitogen-activated protein kinase pathways. Basic Res Cardiol. 2009;104(1):42\u20139.","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"4828_CR91","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1517\/14728222.2016.1111873","volume":"20","author":"R Ramasamy","year":"2016","unstructured":"Ramasamy R, Shekhtman A, Schmidt AM. The multiple faces of RAGE\u2013opportunities for therapeutic intervention in aging and chronic disease. Expert Opin Ther Targets. 2016;20(4):431\u201346.","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"4828_CR92","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.clbc.2017.04.007","volume":"17","author":"K Amornsupak","year":"2017","unstructured":"Amornsupak K, et al. High ASMA(+) fibroblasts and low cytoplasmic HMGB1(+) breast cancer cells predict poor prognosis. Clin Breast Cancer. 2017;17(6):441-452.e2.","journal-title":"Clin Breast Cancer"},{"issue":"11","key":"4828_CR93","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/onc.2016.324","volume":"36","author":"T Kwak","year":"2017","unstructured":"Kwak T, et al. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis. Oncogene. 2017;36(11):1559\u201372.","journal-title":"Oncogene"},{"key":"4828_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040621","author":"MG Muoio","year":"2021","unstructured":"Muoio MG, et al. Activation of the S100A7\/RAGE pathway by IGF-1 contributes to angiogenesis in breast cancer. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13040621.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"4828_CR95","doi-asserted-by":"publisher","first-page":"812","DOI":"10.37349\/etat.2023.00170","volume":"4","author":"G Palanissami","year":"2023","unstructured":"Palanissami G, Paul SFD. AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers. Explor Target Antitumor Ther. 2023;4(5):812\u201349.","journal-title":"Explor Target Antitumor Ther"},{"key":"4828_CR96","doi-asserted-by":"publisher","first-page":"111213","DOI":"10.1016\/j.mce.2021.111213","volume":"527","author":"MW Lero","year":"2021","unstructured":"Lero MW, Shaw LM. Diversity of insulin and IGF signaling in breast cancer: implications for therapy. Mol Cell Endocrinol. 2021;527:111213.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"4828_CR97","doi-asserted-by":"publisher","first-page":"s823","DOI":"10.1093\/ajcn\/86.3.823S","volume":"86","author":"F Xue","year":"2007","unstructured":"Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr. 2007;86(3):s823\u201335.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"4828_CR98","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s13402-015-0263-3","volume":"39","author":"M De Santi","year":"2016","unstructured":"De Santi M, et al. Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor. Cell Oncol (Dordr). 2016;39(2):149\u201359.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"4828_CR99","volume":"14","author":"M Srinivasan","year":"2022","unstructured":"Srinivasan M, et al. A systematic review: does insulin resistance affect the risk and survival outcome of breast cancer in women? Cureus. 2022;14(1):e21712.","journal-title":"Cureus"},{"issue":"4","key":"4828_CR100","volume":"8","author":"D Zooravar","year":"2025","unstructured":"Zooravar D, et al. Association between triglyceride-glucose index and breast cancer: a systematic review and meta-analysis. Cancer Rep (Hoboken). 2025;8(4):e70194.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"1","key":"4828_CR101","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1530\/eje.0.1430085","volume":"143","author":"F Gasc\u00f3n","year":"2000","unstructured":"Gasc\u00f3n F, et al. Sex hormone-binding globulin as a marker for hyperinsulinemia and\/or insulin resistance in obese children. Eur J Endocrinol. 2000;143(1):85\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"4828_CR102","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.tranon.2017.12.009","volume":"11","author":"J Gyamfi","year":"2018","unstructured":"Gyamfi J, et al. Multifaceted roles of Interleukin-6 in adipocyte-breast cancer cell interaction. Transl Oncol. 2018;11(2):275\u201385.","journal-title":"Transl Oncol"},{"key":"4828_CR103","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2147\/CMAR.S403445","volume":"15","author":"I Karadag","year":"2023","unstructured":"Karadag I, et al. The potential prognostic marker TyG Index predicts time to brain metastasis at HER2 positive breast cancer. Cancer Manag Res. 2023;15:311\u20137.","journal-title":"Cancer Manag Res"},{"key":"4828_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010024","author":"L Kern","year":"2018","unstructured":"Kern L, et al. Obesity-induced TNF\u03b1 and IL-6 signaling: the missing link between obesity and inflammation-driven liver and colorectal cancers. Cancers (Basel). 2018. https:\/\/doi.org\/10.3390\/cancers11010024.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"4828_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1107","volume":"11","author":"XY Liu","year":"2023","unstructured":"Liu XY, et al. Prognostic value of insulin resistance in patients with female reproductive system malignancies: a multicenter cohort study. Immun Inflamm Dis. 2023;11(12):e1107.","journal-title":"Immun Inflamm Dis"},{"key":"4828_CR106","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fonc.2015.00157","volume":"5","author":"L Mauro","year":"2015","unstructured":"Mauro L, et al. Cross-talk between Adiponectin and IGF-IR in breast cancer. Front Oncol. 2015;5:157.","journal-title":"Front Oncol"},{"key":"4828_CR107","doi-asserted-by":"publisher","first-page":"1098492","DOI":"10.3389\/fendo.2022.1098492","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, et al. Association between triglyceride glucose index and risk of cancer: A meta-analysis. Front Endocrinol (Lausanne). 2022;13:1098492.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4828_CR108","doi-asserted-by":"publisher","first-page":"1396022","DOI":"10.3389\/fendo.2024.1396022","volume":"15","author":"YY Zhang","year":"2024","unstructured":"Zhang YY, et al. Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms. Front Endocrinol (Lausanne). 2024;15:1396022.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4828_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19106093","author":"D Sat-Mu\u00f1oz","year":"2022","unstructured":"Sat-Mu\u00f1oz D, et al. Adipocytokines and insulin resistance: their role as benign breast disease and breast cancer risk factors in a high-prevalence overweight-obesity group of women over 40 years old. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph19106093.","journal-title":"Int J Environ Res Public Health"},{"key":"4828_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102292","volume":"53","author":"F Li","year":"2025","unstructured":"Li F, et al. Triglyceride-glucose index and triglyceride-glucose-body mass index as prognostic factors for early stage breast cancer patients receiving neoadjuvant chemotherapy. Transl Oncol. 2025;53:102292.","journal-title":"Transl Oncol"},{"key":"4828_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215350","author":"H Shaath","year":"2021","unstructured":"Shaath H, Elango R, Alajez NM. Molecular classification of breast cancer utilizing long non-coding RNA (lncRNA) transcriptomes identifies novel diagnostic lncRNA panel for triple-negative breast cancer. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13215350.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"4828_CR112","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002825","volume":"95","author":"S Nam","year":"2016","unstructured":"Nam S, et al. Association between insulin resistance and Luminal B subtype breast cancer in postmenopausal women. Medicine (Baltimore). 2016;95(9):e2825.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"4828_CR113","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7555\/JBR.34.20200082","volume":"35","author":"Y Yang","year":"2020","unstructured":"Yang Y, Chen X, Ma C. Insulin receptor is implicated in triple-negative breast cancer by decreasing cell mobility. J Biomed Res. 2020;35(3):189\u201396.","journal-title":"J Biomed Res"},{"issue":"1","key":"4828_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170084","volume":"12","author":"HK Bronsveld","year":"2017","unstructured":"Bronsveld HK, et al. Diabetes and breast cancer subtypes. PLoS ONE. 2017;12(1):e0170084.","journal-title":"PLoS ONE"},{"key":"4828_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119838","volume":"562","author":"S Zoroddu","year":"2024","unstructured":"Zoroddu S, et al. Resistin and omentin in breast cancer: a systematic review and meta-analysis. Clin Chim Acta. 2024;562:119838.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"4828_CR116","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-9966-32-14","volume":"32","author":"I Capasso","year":"2013","unstructured":"Capasso I, et al. Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience. J Exp Clin Cancer Res. 2013;32(1):14.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4828_CR117","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1200\/JCO.2009.26.4473","volume":"29","author":"C Duggan","year":"2011","unstructured":"Duggan C, et al. Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol. 2011;29(1):32\u20139.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4828_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099317","volume":"9","author":"AV Hernandez","year":"2014","unstructured":"Hernandez AV, et al. Association between insulin resistance and breast carcinoma: a systematic review and meta-analysis. PLoS ONE. 2014;9(6):e99317.","journal-title":"PLoS ONE"},{"key":"4828_CR119","doi-asserted-by":"publisher","first-page":"1321622","DOI":"10.3389\/fendo.2024.1321622","volume":"15","author":"X Wu","year":"2024","unstructured":"Wu X, et al. Association between triglyceride glucose index and breast cancer in 142,184 Chinese adults: findings from the REACTION study. Front Endocrinol (Lausanne). 2024;15:1321622.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4828_CR120","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s12672-025-04031-8","volume":"16","author":"Q Xie","year":"2025","unstructured":"Xie Q, et al. Triglyceride glucose related indices predict incident breast cancer risk in a population based cohort study. Discov Oncol. 2025;16(1):2205.","journal-title":"Discov Oncol"},{"issue":"1","key":"4828_CR121","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/JCO.2002.20.1.42","volume":"20","author":"PJ Goodwin","year":"2002","unstructured":"Goodwin PJ, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002;20(1):42\u201351.","journal-title":"J Clin Oncol"},{"key":"4828_CR122","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fendo.2020.00058","volume":"11","author":"LD Yee","year":"2020","unstructured":"Yee LD, et al. Metabolic health, insulin, and breast cancer: why oncologists should care about insulin. Front Endocrinol (Lausanne). 2020;11:58.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4828_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112958","author":"R Nehme","year":"2022","unstructured":"Nehme R, et al. Targeting adiponectin in breast cancer. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10112958.","journal-title":"Biomedicines"},{"issue":"6","key":"4828_CR124","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014359","volume":"98","author":"Z Yu","year":"2019","unstructured":"Yu Z, et al. Association of serum adiponectin with breast cancer: a meta-analysis of 27 case-control studies. Medicine (Baltimore). 2019;98(6):e14359.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"4828_CR125","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014094","volume":"98","author":"L Gu","year":"2019","unstructured":"Gu L, et al. Association of serum leptin with breast cancer: a meta-analysis. Medicine (Baltimore). 2019;98(5):e14094.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"4828_CR126","first-page":"79","volume":"61","author":"I Kopriv\u010di\u0107","year":"2022","unstructured":"Kopriv\u010di\u0107 I, et al. Serum leptin level in breast cancer. Acta Clin Croat. 2022;61(1):79\u201385.","journal-title":"Acta Clin Croat"},{"key":"4828_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1465727","volume":"15","author":"CB Lagarde","year":"2024","unstructured":"Lagarde CB, et al. Obesity and leptin in breast cancer angiogenesis. Front Endocrinol (Lausanne). 2024;15:1465727.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7-8","key":"4828_CR128","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.clinbiochem.2013.01.001","volume":"46","author":"M Dalamaga","year":"2013","unstructured":"Dalamaga M, et al. Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters. Clin Biochem. 2013;46(7\u20138):584\u201390.","journal-title":"Clin Biochem"},{"issue":"1","key":"4828_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3877-1","volume":"18","author":"M Patr\u00edcio","year":"2018","unstructured":"Patr\u00edcio M, et al. Using resistin, glucose, age and BMI to predict the presence of breast cancer. BMC Cancer. 2018;18(1):29.","journal-title":"BMC Cancer"},{"key":"4828_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051572","author":"GI Verras","year":"2023","unstructured":"Verras GI, et al. Updated clinical evidence on the role of adipokines and breast cancer: a review. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15051572.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4828_CR131","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s13679-019-00364-y","volume":"8","author":"GS Christodoulatos","year":"2019","unstructured":"Christodoulatos GS, et al. The role of adipokines in breast cancer: current evidence and perspectives. Curr Obes Rep. 2019;8(4):413\u201333.","journal-title":"Curr Obes Rep"},{"issue":"11","key":"4828_CR132","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1097\/gme.0b013e31821e21f5","volume":"18","author":"M Dalamaga","year":"2011","unstructured":"Dalamaga M, et al. Elevated serum visfatin\/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters. Menopause. 2011;18(11):1198\u2013204.","journal-title":"Menopause"},{"key":"4828_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123526","author":"YY Wang","year":"2020","unstructured":"Wang YY, et al. Visfatin enhances breast cancer progression through CXCL1 induction in tumor-associated macrophages. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12123526.","journal-title":"Cancers (Basel)"},{"key":"4828_CR134","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.canlet.2020.10.045","volume":"498","author":"YY Wang","year":"2021","unstructured":"Wang YY, et al. Adipocytokines visfatin and resistin in breast cancer: clinical relevance, biological mechanisms, and therapeutic potential. Cancer Lett. 2021;498:229\u201339.","journal-title":"Cancer Lett"},{"issue":"6","key":"4828_CR135","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41388-018-0477-8","volume":"38","author":"H Goto","year":"2019","unstructured":"Goto H, et al. Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin. Oncogene. 2019;38(6):767\u201379.","journal-title":"Oncogene"},{"issue":"3","key":"4828_CR136","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/bcr3423","volume":"15","author":"WW Chang","year":"2013","unstructured":"Chang WW, et al. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem\/progenitors. Breast Cancer Res. 2013;15(3):R39.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"4828_CR137","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molonc.2015.10.010","volume":"10","author":"CC Engels","year":"2016","unstructured":"Engels CC, et al. The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: a Dutch TEAM substudy analysis. Mol Oncol. 2016;10(4):509\u201316.","journal-title":"Mol Oncol"},{"issue":"1","key":"4828_CR138","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10549-020-05596-4","volume":"181","author":"A Gennari","year":"2020","unstructured":"Gennari A, et al. Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial. Breast Cancer Res Treat. 2020;181(1):61\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"4828_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.641449","volume":"9","author":"A Ianza","year":"2021","unstructured":"Ianza A, et al. Role of the IGF-1 Axis in overcoming resistance in breast cancer. Front Cell Dev Biol. 2021;9:641449.","journal-title":"Front Cell Dev Biol"},{"key":"4828_CR140","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/OTT.S74774","volume":"8","author":"S Yan","year":"2015","unstructured":"Yan S, et al. The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis. Onco Targets Ther. 2015;8:279\u201387.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"4828_CR141","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10549-011-1529-8","volume":"132","author":"R Yerushalmi","year":"2012","unstructured":"Yerushalmi R, et al. Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes. Breast Cancer Res Treat. 2012;132(1):131\u201342.","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"4828_CR142","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","volume":"51","author":"KL Campbell","year":"2019","unstructured":"Campbell KL, et al. Exercise guidelines for cancer survivors: consensus statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019;51(11):2375\u201390.","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"4828_CR143","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13058-018-1051-6","volume":"20","author":"CM Dieli-Conwright","year":"2018","unstructured":"Dieli-Conwright CM, et al. Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial. Breast Cancer Res. 2018;20(1):124.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"4828_CR144","volume":"1","author":"IM Lahart","year":"2018","unstructured":"Lahart IM, et al. Physical activity for women with breast cancer after adjuvant therapy. Cochrane Database Syst Rev. 2018;1(1):Cd011292.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"4828_CR145","first-page":"468","volume":"69","author":"KH Schmitz","year":"2019","unstructured":"Schmitz KH, et al. Exercise is medicine in oncology: engaging clinicians to help patients move through cancer. CA Cancer J Clin. 2019;69(6):468\u201384.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4828_CR146","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/heapro\/daaa072","volume":"36","author":"ML Lim","year":"2021","unstructured":"Lim ML, et al. Association between health literacy and physical activity in older people: a systematic review and meta-analysis. Health Promot Int. 2021;36(5):1482\u201397.","journal-title":"Health Promot Int"},{"key":"4828_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2023.102411","volume":"67","author":"P Mart\u00ednez-Miranda","year":"2023","unstructured":"Mart\u00ednez-Miranda P, et al. Comparative effect of different patient education modalities on quality of life in breast cancer survivors: A systematic review and network meta-analysis. Eur J Oncol Nurs. 2023;67:102411.","journal-title":"Eur J Oncol Nurs"},{"key":"4828_CR148","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60111893","author":"P Cespedes","year":"2024","unstructured":"Cespedes P, et al. Impact of a physical exercise and health education program on metabolic syndrome and quality of life in postmenopausal breast cancer women undergoing adjuvant treatment with aromatase inhibitors. Medicina (Kaunas). 2024. https:\/\/doi.org\/10.3390\/medicina60111893.","journal-title":"Medicina (Kaunas)"},{"issue":"10","key":"4828_CR149","doi-asserted-by":"publisher","first-page":"11703","DOI":"10.1002\/cam4.5545","volume":"12","author":"Y Lu","year":"2023","unstructured":"Lu Y, et al. Breast cancer risk for women with diabetes and the impact of metformin: a meta-analysis. Cancer Med. 2023;12(10):11703\u201318.","journal-title":"Cancer Med"},{"issue":"20","key":"4828_CR150","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1001\/jama.2022.6147","volume":"327","author":"PJ Goodwin","year":"2022","unstructured":"Goodwin PJ, et al. Effect of metformin vs placebo on invasive disease-free survival in patients with breast cancer: the MA.32 randomized clinical trial. JAMA. 2022;327(20):1963\u201373.","journal-title":"JAMA"},{"issue":"6","key":"4828_CR151","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41416-023-02204-2","volume":"128","author":"SR Lord","year":"2023","unstructured":"Lord SR, Harris AL. Is it still worth pursuing the repurposing of metformin as a cancer therapeutic? Br J Cancer. 2023;128(6):958\u201366.","journal-title":"Br J Cancer"},{"issue":"2","key":"4828_CR152","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3390\/curroncol28020134","volume":"28","author":"T Farkhondeh","year":"2021","unstructured":"Farkhondeh T, et al. Impact of metformin on cancer biomarkers in non-diabetic cancer patients: a systematic review and meta-analysis of clinical trials. Curr Oncol. 2021;28(2):1412\u201323.","journal-title":"Curr Oncol"},{"issue":"48","key":"4828_CR153","doi-asserted-by":"publisher","first-page":"84224","DOI":"10.18632\/oncotarget.20478","volume":"8","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, et al. A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer. Oncotarget. 2017;8(48):84224\u201336.","journal-title":"Oncotarget"},{"issue":"3","key":"4828_CR154","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/10600280211025792","volume":"56","author":"K Morio","year":"2022","unstructured":"Morio K, et al. Efficacy of metformin in patients with breast cancer receiving chemotherapy or endocrine therapy: systematic review and meta-analysis. Ann Pharmacother. 2022;56(3):245\u201355.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"4828_CR155","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00228-022-03444-6","volume":"79","author":"AA El-Attar","year":"2023","unstructured":"El-Attar AA, et al. Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study. Eur J Clin Pharmacol. 2023;79(2):299\u2013309.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"4828_CR156","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10549-023-07241-2","volume":"205","author":"H Johansson","year":"2024","unstructured":"Johansson H, et al. Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials. Breast Cancer Res Treat. 2024;205(1):49\u201359.","journal-title":"Breast Cancer Res Treat"},{"key":"4828_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/biology14050539","author":"L Wei","year":"2025","unstructured":"Wei L, et al. Elucidating the prognostic and therapeutic implications of insulin resistance genes in breast cancer: a machine learning-powered analysis. Biology. 2025. https:\/\/doi.org\/10.3390\/biology14050539.","journal-title":"Biology"},{"issue":"10","key":"4828_CR158","doi-asserted-by":"publisher","first-page":"bqab147","DOI":"10.1210\/endocr\/bqab147","volume":"162","author":"T Mathur","year":"2021","unstructured":"Mathur T, Yee D. The emerging role of the fetal insulin receptor in hormone-refractory breast cancer. Endocrinology. 2021;162(10):bqab147.","journal-title":"Endocrinology"},{"issue":"11","key":"4828_CR159","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.3390\/ijms19113615","volume":"19","author":"V Vella","year":"2018","unstructured":"Vella V, et al. Insulin receptor isoforms in cancer. Int J Mol Sci. 2018;19(11):3615.","journal-title":"Int J Mol Sci"},{"key":"4828_CR160","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091017","author":"V Vella","year":"2019","unstructured":"Vella V, et al. Insulin receptor isoform A modulates metabolic reprogramming of breast cancer cells in response to IGF2 and insulin stimulation. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8091017.","journal-title":"Cells"},{"key":"4828_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241915006","author":"MA Galal","year":"2023","unstructured":"Galal MA, et al. Insulin receptor isoforms and insulin growth factor-like receptors: implications in cell signaling, carcinogenesis, and chemoresistance. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241915006.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4828_CR162","doi-asserted-by":"publisher","first-page":"21473","DOI":"10.1038\/s41598-021-00335-1","volume":"11","author":"G Anvari","year":"2021","unstructured":"Anvari G, Bellas E. Hypoxia induces stress fiber formation in adipocytes in the early stage of obesity. Sci Rep. 2021;11(1):21473.","journal-title":"Sci Rep"},{"issue":"4","key":"4828_CR163","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/jnci\/93.4.309","volume":"93","author":"R Bos","year":"2001","unstructured":"Bos R, et al. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst. 2001;93(4):309\u201314.","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"4828_CR164","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1158\/1078-0432.CCR-05-2690","volume":"12","author":"D Generali","year":"2006","unstructured":"Generali D, et al. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res. 2006;12(15):4562\u20138.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"4828_CR165","doi-asserted-by":"publisher","first-page":"11238","DOI":"10.18632\/oncotarget.7167","volume":"7","author":"MW Alam","year":"2016","unstructured":"Alam MW, et al. HIF2\u03b1 contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells. Oncotarget. 2016;7(10):11238\u201350.","journal-title":"Oncotarget"},{"issue":"2","key":"4828_CR166","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-012-2376-y","volume":"137","author":"J Bostner","year":"2013","unstructured":"Bostner J, et al. Activation of Akt, mTOR, and the estrogen receptor as a signature to predict Tamoxifen treatment benefit. Breast Cancer Res Treat. 2013;137(2):397\u2013406.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"4828_CR167","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1159\/000354757","volume":"8","author":"SP Hasson","year":"2013","unstructured":"Hasson SP, et al. Endocrine resistance in breast cancer: focus on the phosphatidylinositol 3-kinase\/akt\/mammalian target of rapamycin signaling pathway. Breast Care (Basel). 2013;8(4):248\u201355.","journal-title":"Breast Care (Basel)"},{"issue":"8","key":"4828_CR168","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","volume":"7","author":"AACR Project GENIE","year":"2017","unstructured":"AACR Project GENIE. Powering Precision Medicine through an International Consortium. Cancer Discov. 2017;7(8):818\u201331.","journal-title":"Cancer Discov"},{"issue":"13","key":"4828_CR169","doi-asserted-by":"publisher","first-page":"9817","DOI":"10.1074\/jbc.M010840200","volume":"276","author":"RA Campbell","year":"2001","unstructured":"Campbell RA, et al. Phosphatidylinositol 3-kinase\/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem. 2001;276(13):9817\u201324.","journal-title":"J Biol Chem"},{"issue":"7719","key":"4828_CR170","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","volume":"560","author":"BD Hopkins","year":"2018","unstructured":"Hopkins BD, et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature. 2018;560(7719):499\u2013503.","journal-title":"Nature"},{"issue":"1","key":"4828_CR171","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13058-024-01773-1","volume":"26","author":"J Rod\u00f3n","year":"2024","unstructured":"Rod\u00f3n J, et al. A risk analysis of Alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer. Breast Cancer Res. 2024;26(1):36.","journal-title":"Breast Cancer Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04828-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04828-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04828-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:02:43Z","timestamp":1777532563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04828-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":171,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4828"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04828-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed and approved the final version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"662"}}